5-Bromo-2-ethylbenzo[d]oxazole

Catalog No.: 
ACXNKG015
CAS No.: 
938458-80-1
Molecular Formula: 
C9H8BrNO
Molecular Weight: 
226.07
5-Bromo-2-ethylbenzo[d]oxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$65.00In stockInquiry
5g98%$233.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-ethylbenzo[d]oxazole
IUPAC Name5-bromo-2-ethylbenzo[d]oxazole
MDL No.B195950
Molecular FormulaC9H8BrNO
Molecular Weight226.07
SMILESCCC1=NC2=C(O1)C=CC(Br)=C2
InChI KeyFEFKLDDJMPFJHS-UHFFFAOYSA-N
Synonym5-Bromo-2-ethylbenzo[d]oxazole | 938458-80-1 | 5-bromo-2-ethyl-1,3-benzoxazole | 5-bromo-2-ethylbenzoxazole | MFCD09055180 | SCHEMBL17876424 | DTXSID90650750 | AKOS005072657 | FC-0721 | SY018738 | CS-0152478 | FT-0681014 | O11364 | A852418 | J-516920
CAS No.938458-80-1
PubChem CID27282741

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACXNKG015 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIXVK264 route compound structure diagram
    ACIXVK26440925-68-6In Stock
  2. Then
  3. ACXNKG015 route product structure diagram
    ACXNKG015938458-80-1In Stock
Inquiry

2. ACXNKG015 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADFR680 route compound structure diagram
    ACADFR680137-40-6In Stock
  2. Plus
  3. ACIXVK264 route compound structure diagram
    ACIXVK26440925-68-6In Stock
  4. Then
  5. ACXNKG015 route product structure diagram
    ACXNKG015938458-80-1In Stock
Inquiry

3. ACXNKG015 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXNKG015 route product structure diagram
    ACXNKG015938458-80-1In Stock
Inquiry

Comments (0)